A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1
Clinical trial NCT03776071 · COMPLETED
Trial details
- NCT number
- NCT03776071
- Sponsor
- Denovo Biopharma LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-16
- Primary completion
- 2024-02-29
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.